Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 3 subfamily A member 1 (OR3A1) is a human G protein-coupled receptor (GPCR) that detects odors by binding specific volatile molecules in the nasal epithelium, initiating signal transduction leading to the perception of smell[3][4][6]. OR3A1 is part of the large olfactory receptor family, all encoded by single-exon genes, structurally unified by a 7-transmembrane domain typical of GPCRs[3][6]. OR3A1 recognizes certain odorant compounds, including *helional*, *heliotropylacetone*, *lilial*, *cyclamen aldehyde*, and *foliaver*, which then activate the receptor[4]. OR3A1 and similar olfactory receptors are not considered therapeutic targets in current clinical practice or drug development, and have no established role in disease or as drug targets[3][4].
Not applicable (endogenous ligands are odorant molecules; not therapeutically targeted by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 3 subfamily A member 1 (OR3A1).